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Peripheral Arterial Occlusions: Local Low-Dose Thrombolytic 
Therapy with Recombinant Tissue-Type Plasminogen Activator 
(rt-PA) 
H. Hess, A. Mietaschk, P. von Bilderling and P. Neller* 
Klinik Diakoniewerk, Manchen-Maxvorstadt, Munich 
Objective: To study the efficacy and risks of local thrombolytic therapy of peripheral arterial occlusions using rt-PA. 
Design: This open study was performed in one clinic in Munich, Germany. 
Methods: 288 patients uffering from occlusions of the lower limb arteries were subjected to 336 treatments performed with 
a permanently controlled technique. In a short pilot study lOmg rt-PA/h were administered for 5 h but in the majority of 
the cases only 2.Smg/h were administered for a maximum of 5 h. The average total dose of rt-PA zoas 2.97mg and the 
average time for lysis was 78 rain. 
Results: 43 (84.3%) out of 51 embolic occlusions and 168 (71.5%) out of 235 thrombotic occlusions were recanalised with 
a cumulative patency of 95% and 79.7% respectively after 2 years. One systemic bleeding occurred in the pilot study with 
lOmg rt-PA / h whereas with the 2.5mg / h dosage no systemic bleeding or embolism occurred in the 315 treatments. There 
were no deaths during hospitalisation. Six major and two forefoot amputations were necessary. Thirteen patients required 
a bypass operation and one an embolectomy. The advantages of our controlled technique are: short duration of treatment, 
small doses of activating agent, an accurately directed pathway with the possibility of dilating stenoses during the same 
session, no danger of systemic bleeding or embolism and, therefore, good prospects of success with minimal risk. 
Conclusion: The use of rt-PA for local lysis substitutes the inadequate tissue activator available for effective spontaneous 
lysis and is, therefore, almost physiological. The effect of a very low dose of rt-PA was as good as that of higher doses. 
Key Words: Peripheral arterial occlusions; Critical ischaemia; Local thrombolysis; Recombinant tissue-type plasminogen 
activator. 
Introduction 
Local thrombolysis is an alternative to the surgical 
treatment of peripheral arterial occlusions. It is only 
effective, however, when the occlusion is due to a 
lesion which is still capable of being lysed i.e. it must 
contain non-organised fibrin. In addition, thrombo- 
lysis is a justifiable alternative only when the pros- 
pects of success are comparable to those of surgery 
and when the risks are not greater. As with vascular 
surger~ specialists in thrombolytic therapy have used 
different echniques with various thrombolytic agents 
in varying doses and have obtained varying results. 
We now have 14 years experience with over 1000 
cases of peripheral arterial occlusions treated by local 
*The follow-up investigations of the patients and statistical evalua- 
tion of the data were performed by Petra Neller as part of her 
dissertation for a doctorate from the Medical Faculty of the Ludwig- 
Maximilian University, Munich 
thrombolysis. During the first 6 years we used 
streptokinase (SK) and urokinase (UK). ~ Since Novem- 
ber 1986 a genetically engineered recombinant tissue- 
type plasminogen activator (rt-PA) has been available 
to us. Physiologically this activator is synthesised in 
vessel endothelium and when released locally it lyses 
intravascular thrombi spontaneously, requiring only 
minimal quantities. With thrombi in vessels with 
arteriosclerotic changes, however, adequate sponta- 
neous lysis very seldom occurs, the reason for this is 
that probably because the diseased artery cannot 
synthesise and release sufficient amounts of plasmino- 
gen activator. The controlled introduction of rt-PA into 
an obstructing thrombus substitutes this deficiency 
and succeeds in dissolving the thrombus in an almost 
physiological way. For this, as with spontaneous lysis, 
only minimal amounts of rt-PA are required. Unlike 
SK or UK, rt-PA has little affinity for free circulating 
plasminogen but high affinity for fibrin-bound plas- 
minogen and has a short half-life of only 3-6 min. 2 
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We report here our results and experience with local 
thrombolytic treatment of peripheral arterial occlu- 
sions with rt-PA. 
Material and Methods 
Patients 
Within a period of 4 years we treated 288 patients 
suffering from peripheral arterial occlusion with local 
low-dose thrombolytic therapy with rt-PA. Of these 16 
patients had occlusions in both legs and these were 
treated uring two sessions with an interval of at least 
2 days between them. There were, therefore, alto- 
gether 304 peripheral occlusions. 
Of the 288 patients 139 were male and 149 female 
with ages ranging between 24 and 88 years (average 
71 years). Two hundred and thirty-five of the 304 
arterial occlusions were due to thromboses, 41 to 
primary emboli, 10 to emboli secondary to balloon 
angioplasty and 18 were graft occlusions. 
Localisation of the occlusions was as follows: 
Superficial femoral artery down to the popliteal artery 
excluding the trifurcation 202 (of which 18 were 
grafts); femoropopliteal segment including the tri- 
furcation 92; iliac artery 4; isolated occlusions of the 
arteries in the calf 6. 
Dosage 
In association with a multicentre study the first 10 
patients received 10 mg rt-PA per hour for a maximum 
of 5 h. The total dose fluctuated between 10 and 50 mg 
rt-PA (average 15.75 mg) and the duration of treat- 
ment between 60 and 300 min (average 107 min). 3 
Eleven treatments were performed using 5 mg rt-PA 
per hour. The total dose here fluctuated between 0.88 
and 12.75 mg (average 7.8 mg) and the duration of 
treatment between 15 and 160 min (average 92 min). 
In the remaining 283 treatments 2.5 mg rt-PA per hour 
was administered. The total dose varied between 0.4 
mg and 12.5 mg (average 2.97 mg) and the duration of 
treatment between 10 and 385 min (average 78 min). 
Technique 
In comparison to our study with streptokinase and 
urokinase 1 the technical procedure was changed only 
in that instead of giving the thrombolytic agent 
intermittently at intervals of 3 min, rt-PA was admin- 
istered as a continuous infusion of 0.5 ml solution per 
min. In order to infiltrate the thrombus it is important 
that a simple catheter (5, 6 or 7 French) with only one 
terminal opening is used and as a rule this is 
introduced in the direction of the occlusion via an 
ipsilateral puncture of the common femoral artery. 
With occlusions of the pelvic artery or the common 
femoral artery and its bifurcation, a cross-over tech- 
nique may be necessary for introducing the catheter. 
In contrast to other techniques in which a catheter is 
introduced into the occlusion and through which the 
thrombolytic agent is infused for many hours with the 
catheter remaining in the same position, in our 
procedure the attending physician remains with the 
patient throughout he entire intervention which is 
always performed under local anaesthesia and with- 
out any premedication. With a continuous infusion the 
catheter is advanced stepwise so that each stenosis is 
recognised. In this way lysis of even extensive thrombi 
can be achieved in the shortest possible time with a 
minimum amount of thrombolytic agent. In addition, 
residual high-grade stenoses can be identified and 
dilated during the same session. 
Prophylaxis 
In order to prevent early reocclusion each patient 
received I g of acetylsalicylic acid commencing on the 
day before the intervention and thereafter for at least 
10 days. In contrast to treatment with SK, low-dose rt- 
PA gives rise to only small amounts of heparin - like 
fibrinogen split products. It is, therefore, necessary to 
give 5000 IU of heparin during the intervention. With 
local lysis of lengthy thrombotic occlusions or with 
poor outflow it is advisable to give heparin i.v. or s.c. 
monitored by PTT values for a further 2-3 days and 
then a platelet aggregation inhibitor alone for long- 
term therapy. With local lysis of primary embolic 
occlusions, long-term anticoagulation therapy alone is 
used for the prevention of recurrent emboli. Heparin 
is given concomitantly with phenprocoumon u til the 
Quick-Test value has reached 30% and thereafter long- 
term anticoagulation therapy is continued with phen- 
procoumon alone. We proceed in the same way 
following successful lysis of a graft occlusion as we 
believe that anticoagulation is more effective than 
platelet aggregation inhibition in preventing new 
occlusions. 
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Table 1. Early results of local Iow-d0se thrombolytic therapy with rt-PA for arterial occlusions in 304 lower extremities of 288 
consecutively treated patients 
Recanalisafion lasting 
Recanalisations Early reocclusions 2 weeks 
Type of Occlusions 
ocdusions/ treatment (n) n % n % n % 
All occlusions 
First lysis 304 272 (89.5) 65 (23.9) 207 (68.0) 
Second lysis 33 31 (93.9) 12 (38.7) 19 (57.6) 
Total interventions (n=336) 226 (74.3) 
Embolic occlusions 
First lysis 41 39 (95.1) 7 (17.9) 32 (78.0) 
Second lysis 2 2 (100.0) 0 (0.0) 2 (100.0) 
Total interventions (n=43) 34 (82.9) 
Macroemboli after primary dilation 10 9 (90.0) 0 (0.0) 9 (90.0) 
(n=10) 
Thrombotic o clusions 
First lysis 235 207 (88.1) 51 (24.6) 156 (66.4) 
Second lysis 25 24 (96.0) 12 (50.0) 12 (48.0) 
Total interventions (n=260) 168 (71.5) 
Grafts 
First lysis 18 17 (94.4) 7 (41.2) 10 (55.6) 
Second lysis 6 5 (83.3) 0 (0.0) 5 (100.0) 
Total interventions (n=23) 15 (83.3) 
Long-term study and statistical methods 
All patients underwent a clinical examination 2 weeks 
after local lysis. This included palpation of the 
peripheral pulses, auscultation of the vessels, ultra- 
sound Doppler pressure values and Duplex sono- 
graphy. If there was any doubt angiography was also 
performed. Patients who did not have successful 
recanalisation at that time were considered to be 
failures. 
All patients in whom successful recanalisation had 
persisted for 14 days were contacted by telephone or 
in writing using a standard questionnaire. Every 
patient who indicated even only the slightest deteri- 
oration in h is /her  symptoms ince the primary suc- 
cessful treatment using the above mentioned methods 
was requested to,attend for a follow-up examination. 
The purpose of the investigation was to show whether 
an occlusion or a haemodynamical ly effective stenosis 
(greater than 70%) had occurred in the treated vessel 
segment. In patients who admitted to a deterioration 
in their condition but who failed to attend for follow- 
up examination it was assumed that an occlusion had 
occurred. Three patients could not be traced and 27 
patients died during the period of observation. The 
cumulative patency was determined by means of the 
life-table method. 4 
Results 
Early results 
Early results of 304 peripheral arterial occlusions in 
288 consecutive patients treated with local rt-PA are 
summarised in Table 1. Two hundred and seventy-two 
of these occlusions could be reopened primarily and 
65 of these had early reocclusions within the first 2 
weeks. A second lysis was attempted in 33 of these 
early reocclusions, 19 of which remained successful 
for 2 weeks. Thus 74.3% of all occlusions were treated 
successfully. 
Early success in 41 embolic occlusions was higher 
(82.9%) compared to 235 thrombotic occlusions 
(71.5%). Macroemboli resulting from primary angio- 
plasty were rapidly dissolved in nine out of 10 cases. 
Seventeen out of 18 occlusions in femoropopliteal or
femorocrural prostethic grafts were opened primarily; 
seven of these had early reocclusions of which five 
remained open for 2 weeks following a successful 
second lysis. Thus, from 19 occluded grafts 15 (83.3%) 
were treated successfully. In 10 patients the cause of 
the occlusion was stenosis of the distal anastomosis 
which in seven cases could be successfully removed 
by dilatation. In one case the runoff route was 
corrected surgically subsequent to successful primary 
lysis and at the same time an AV shunt was 
performed. 
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Table 2. Early results of local low-dose thrombolytic therapy with 
rt-PA in embolic and thrombotic occlusions in the lower 
extremities as a function of the type and age of the occlusions 
Recanalisation 
lasting 2 weeks 
Type and age Occlusions Recanalisation 
of ocdusions (n) (n) n % 
Embolic (n=51) 
<6 weeks 41 39 34 (82.9) 
Macroemboli after 
primary dilation 10 9 9 (90.0) 
Thrombotic (n=235) 
>6 months 37 28 25 (67.6) 
<6 months 198 178 143 (72.7) 
Grafts @=18) 
>4 weeks 5 3 2 (40.0) 
<4 weeks 13 13 13 (100.0) 
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Fig. 2. Recanalisation as a function of the length of the occlusion 
(percentage of recanalised occlusions in each group). (V]) primary 
results; ( . )  recanalised vessels till patent after 2 weeks. Macro- 
emboli after primary dilatation (n = 10) and isolated occlusions of 
the arteries in the calf (n = 6) are not included in this group. 
Of the 304 occlusions treated with local lysis, 175 
(57.6%) were also dilated. Of these six (14.6%) were 
from 41 embolic occlusions, 156 (66.4%) from 235 
thrombotic occlusions, 10 (55.6%) from 18 graft occlu- 
sions and three (30.0%) from 10 occlusions caused by 
macroemboli following angioplasty. 
The chances of success of local lysis with rt-PA 
depending on the type and duration of an occlusion is 
shown in Table 2. Particularly rapid thrombolysis of 
longer arterial occlusions was achieved regularly 
when these were just a few days old. Occlusions of 
prosthetic grafts less than 4 weeks old were success- 
fully lysed in 100% of cases. If the occlusion was 
between 4 and 16-weeks-old, successful lysis was 
achieved in only 40%. The results with over 6 months 
old thrombotic occlusions treated with rt-PA were also 
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Fig. 1. Recanalisation as a function of the Fontaine stage of the 
disease (percentage of recanalised occlusions in each group). Stage 
IIA = pain-free walking distance > 250 m, IIB= pain-free walking 
distance < 250 m, I I I= pain at rest, IV = necrosis, gangrene. (E3) 
primary results; (Ill) recanalised vessels till patent after 2 weeks. 
remarkably good, 75.7% primary patency with 67.6% 
still open after 2 weeks. 
The severity of the circulatory disturbances accord- 
ing to the Fontaine classification did not influence the 
early results. The 2 weeks patency rate after treatment 
were practically the same with 63.8 to 69.7% in all 
stages (Fig. 1). The early success, however, did depend 
upon the length of the occlusion; with 2 weeks 
continuous recanalisation of occlusions less than 5 cm 
it was 80.8%, with 5-10 cm 69.2%, and from 10 to over 
25 cm 55% (Fig. 2). 
We observed that older patients had better early 
results of local lysis with rt-PA. Recanalisation was 
primarily successful in about 90% of patients regard- 
less of age. In contrast, success was maintained for 2 
weeks only in 50% of patients under the age of 50 
whereas in those between 51 and 60 it was 57%, 
between 61 and 70, 69%, between 71 and 80, 66% and 
over 80 it was 78% (Fig. 3). 
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Fig. 3. Recanalisation as a function of the age of the patients 
(percentage of recanalised occlusions in each group). (E~) primary 
results; (n) recanalised vessels till patent after 2 weeks. 
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Long-term results 
Of 304 arterial occlusions in 288 patients 226 could be 
opened by local lysis with rt-PA and the success was 
maintained continuously for 2 weeks. In three patients 
the further course could not be ascertained. The 
cumulative patency calculated from 223 peripheral 
occlusions treated successfully with rt-PA was 81.9% 
after 2 years and also after 4 years. The results after 4 
years, however, are not reliable because of the small 
number of patients followed up for so long. Macro- 
emboli following primary catheter dilatation have the 
best long-term prognosis with 100%, followed by 
primary embolic occlusions with 94.7% patency after 4 
years. This is followed by thrombotic occlusions with 
79.7% and then graft occlusions with 67.2% (Fig. 4). In 
some of our patients, however, haemodynamical ly 
significant stenoses have recurred over the years. The 
overall 2 years patency without any high-grade 
haemodynamical ly effective Stenosis was 61.7%. 
Cumulative long-term patency was found to be 
independent of the age and sex of the patient. 
Successfully treated occlusions of the popliteal artery 
including the trifurcation have an unexpected good 
long-term prognosis (89.0%) which is not significantly 
different when compared to segmental occlusions of 
the femoral or popliteal arteries with open trifucation 
(78.8%) (p = 0.128). Segmental occlusions up to 25 cm 
length have practically as good a chance after 2 years 
with patency between 79 and 89.4%; with even longer 
occlusions the value is only 65.3%. 
Long-term prognosis also depends on the clinical 
presentation at the time of treatment. In Fontaine 
Stage IIA patients, cumulative patency after 2 years is 
100%, in Stages IIA and III patients it is 83% and in 
Stage IV patients 51% (p < 0.01). 
Failures and complications 
The main reason for failure of treatment was penetra- 
tion of the catheter into the vessel wall which occurred 
in 9% of the 336 treatments with lysis. In 7% of the 
treatments either the thrombus was organised and the 
catheter could no longer pass through or the guide 
wire constantly diverged off into a collateral vessel. 
All complications which occurred during the inter- 
ventions and during inpatient treatment are sum- 
marised in Table 3. In 26 (7.7%) treatments a periph- 
eral macroembolus into run-off vessels occurred of 
which 22 were dissolved either during the inter- 
vention under continued local lysis or some hours 
later by the after-lysis effect. The remaining four 
macroembolisms did not give rise to any deteriora- 
tion. The only systemic haemorrhage with rt-PA was 
gastric bleeding in a patient who had received 10 mg 
rt-PA per hour for 5 h i.e. a total of 50 fng together with 
5000 IU heparin. Of seven haematomas at puncture 
sites, six (1.7%) were of moderate size, one (0.3%) 
required volume substitution but none needed surgi- 
cal evacuation. 
Major amputations (below knee, above knee) were 
necessary in two patients after unsuccessful lysis and 
in four further cases following late reocclusions. Two 
patients had forefoot and toe amputations respec- 
tively. Bypass operations were necessary in four cases 
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Fig. 4. Cumulative patency (%) within 4 years after ecanalisation with local ow-dose thrombolytic therapy with rt-PA lasting almost 2 
weeks as a function of the type of the occlusion. The 4 different lines indicate this in sequence from top to bottom in the eight macroembolic 
occlusions occurring as a complication f primary angioplasty, in the 34 embolic occlusions, inthe 166 thrombotic ocdusions and in the 15 
occlusions of femoropopliteal/crural bypasses. 
Eur J Vasc Endovasc Surg Vol 12, July 1996 
102 H. Hess et aL 
Table 3. Complications arising in 288 patients receiving local low- 
dose thrombolytic treatments with rt-PA 
Patients/treatment n % 
Complications 
Macroembolism 26 (7.7) 
Macroembolism with deterioration 0 (0.0) 
Extension ofthrombosis after balloon dilation 3 (0.9) 
Amputation because deterioration after treatment 0 (0.0) 
Spasm of the femoral/popliteal artery 1 (0.3) 
Large haematoma at the puncture site 
(no surgical intervention needed) 7 (2.0) 
Systemic bleeding 
intestinal 1 (0.3)* 
cerebral 0 (0.0) 
renal 0 (0.0) 
Cerebral embolism 0 (0.0) 
Hospital deaths 0 (0.0) 
*Patient receiving 50 mg rt-PA + 5000 IU heparin within 5 h. 
following unsuccessful lysis, in two after early occlu- 
sions within 2 weeks after lysis and in three after late 
reocclusions. A further four patients had aneurysms of
the popliteal artery removed by graft operations. In 
one case it was necessary to perform embolectomy to 
restore the vascular circulation after both lysis and 
aspiration had proved to be unsuccessful. 
Discussion 
Early and long-term results with local low-dose rt-PA 
thrombolytic therapy are better than those which we 
obtained in previous years with SK and UK. 1 From 
this it can be concluded without any doubt that local 
thrombolytic treatment has become more successful 
from study to study. This is certainly due in part to our 
increasing experience with diagnosis and technique. 
The superiority of rt-PA over SK and UK cannot be 
unequivocally deduced from these results and can 
only be determined in a randomised study. 
Even more caution is required when our results are 
compared with those of other authors who used other 
methods and different doses of SK, UK or rt-PA over 
varying periods of time for local thrombolytic treat- 
ment. 5-~4 Further, in such a comparison the patient 
populations under investigation must be comparable 
particularly with regard to how long the occlusion has 
existed and also the type (thrombotic, embolic). Our 
early results with 89.5% primary recanalisations of all 
types of occlusions are, nevertheless, comparable to 
the best results of all published studies to date. As far 
as studies with rt-PA are concerned, these results were 
achieved with the smallest doses mentioned until 
now, namely 0.4 mg to 15.5 mg (average total 2.97 mg 
rt-PA) and a treatment time of 10 to 385 min (average 
78 min). In a comparable study in which 10 mg rt-PA 
were infused blindly for a period of 6 h each time via 
a catheter placed at the proximal end of the occlusion, 
patency was achieved in 31% of the cases after 6 h 
treatment (10 mg rt-PA), in 60.5% after 12 h (20 mg rt- 
PA) and in 67.1% after 24 h (40 mg rt-PA), s Another 
study treated 15 femoropopliteal bypass occlusions 
and a segmental femoral arterial occlusion with 10 mg 
rt-PA as a bolus followed by 5 mg/hour as a blind 
local infusion up to a maximum of 24 h and achieved 
patency in 25% of the cases after 4 h (30 mg rt-PA), in 
44% after 8-16 h (50-90 mg rt-PA) and in only 50% 
after 24 h (130 mg rt-PA). The average age of the 
occlusions here was only 9.3 days. 6
The main reasons for early reocclusions following 
successful recanalisation were slowing of the blood 
flow due to poor run-off in the periphery and high- 
grade residual stenoses which we had underesti- 
mated. Most bypass occlusions were due to disparity 
between the diameter of the graft and the artery of the 
distal anastomosis or a reocclusion of the latter due to 
high-grade stenosis. Dilatation of high-grade stenoses 
should generally be performed during the same 
session and should be strictly limited to the stenosed 
segment. 
In many centres occlusions in femoropopliteal or
femorocrural grafts are managed surgically. In 15 out 
of 18 such occlusions continuous patency was 
achieved by local lysis although five required asecond 
lysis. We recommend that whenever possible local 
lysis should always be attempted first with graft 
occlusions. 
The strategy of treating acute peripheral ischaemia 
should be reconsidered. Until now acute critical 
ischaemias, i.e. threatened viability or irreversible 
ischaemic hanges has been managed surgically to 
provide rapid revascularisation. This is true as far as 
acute embolic occlusions of the arteries of the arms, 
the abdominal aorta, the pelvic arteries, the common 
femoral arteries and their bifurcations are concerned. 
With embolic occlusions of the superficial femoral 
arteries, popliteal arteries and arteries of the lower leg, 
embolectomy in the first days following the acute 
incident has a high probability of success, however, 
becoming less so from day to day. Follow-up inves- 
tigations in patients who had had embolectomy of the 
femoropopliteal segment have shown that only one 
third was permanently successful, one third was 
unsuccessful from the beginning and the remaining 
third showed angiographic evidence of arteriosclerotic 
changes in the section of the vessel through which the 
balloon catheter had been drawn. 17 It is necessary to 
consider further that in many cases it can be difficult 
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to distinguish embolus from thrombus. In thrombotic 
occlusions a Fogarty embolectomy has little prospect 
of success and local lysis following it has also 
unfortunately no greater success. Where critical 
ischaemia is present in the case of a thrombotic 
occlusion a femorocrural bypass with all its problems 
is usually performed. When local lysis is the inter- 
vention of choice it is immaterial whether the acute 
occlusion is embolic or thrombotic. In our experience, 
in both embolic and thrombotic acute occlusions of the 
femoropopliteal nd femorocrural rteries with critical 
ischaemia, local lysis can restore the blood flow 
practically as quickly and with at least the same 
prospect of success as surgical procedures. Should the 
intervention fail, immediate surgical procedures are 
possible. When this occurs, in most cases conditions 
are not any worse than they were before the unsuc- 
cessful ocal lysis. It must be admitted, however, that 
further deterioration i the blood flow can occur as a 
complication of the lytic procedure which could make 
the previous possibility of surgery more difficult or 
even impossible. Therefore, modern treatment of acute 
critical ischaemia requires close cooperation between 
angiologists, radiologists performing the intervention 
and vascular surgeons. 
In our 336 treatments with rt-PA we had no hospital 
deaths, no new systemic embolization and only one 
systemic (gastrointestinal) bleeding following 10 mg 
rt-PA per hour for 5 h (total dose 50 mg) and 5000 IU 
heparin. In 1.7% of the treatments evere bleeding 
occurred from the puncture site and of these one 
patient (0.3%) required volume replacement therapy 
but none required surgical care. In the studies already 
mentioned in which higher doses of rt-PA and longer 
periods of treatment were required, bleeding compli- 
cations were considerably more frequent particularly 
where 30-130 mg of rt-PA were administered over 
4-24 h. 5"6 In a literature review on local thrombolytic 
treatments with different echniques, drugs and dos- 
ages, the following averages are cited: 2% extensive 
bleeding from the puncture site requiring surgical 
treatment, about 1% severe systemic bleeding (cere- 
bral, gastrointestinal renal) and 1.1% hospital deaths 
correlated to treatment. ~s Some of the bleeding com- 
plications were certainly due to the administration of 
heparin which in most cases was given concomitantly. 
Heparin was also used in our study so that it can be 
assumed that the low total doses of rt-PA was 
followed by less local bleeding complications. 
We feel there are very few contraindications to local 
lysis using very low-dose rt-PA. Even if there is no risk 
of a substantial ctivation of systemic fibrinolysis with 
very low doses rt-PA, florid gastrointestinal and 
cerebral haemorrhages still remain contraindications. 
A further contraindication is a sufficiently well com- 
pensated occlusion of the popliteal artery based on an 
aneurysm of this vessel. When this, however, is 
accompanied by critical ischaemia nd the angiogram 
shows concomitant occlusion of all three large arteries 
of the lower limb, then the prospect exists, as in three 
of our cases, that local lysis will reopen peripheral 
arteries allowing surgical removal of the aneurysm. 
From the results of our study we conclude that local 
thrombolytic treatment of peripheral arterial occlu- 
sions with 2.5 mg rt-PA per hour for a maximum of 
3-5 h using the technique recommended by us has 
good prospects of success with hardly any risk of 
systemic bleeding or embolisation. Monitoring of 
coagulation parameters is, therefore, not necessary. 
Our continuous controlled method has several advan- 
tages compared to the methods where a catheter is 
placed directly at the origin of an occlusion or even 
inserted into it and then rt-PA is infused for several 
hours in an uncontrolled way. They are as follows: (1) 
The total dose of rt-PA required is low (in our case an 
average of 2.97 mg). Because of this there is hardly any 
risk of bleeding or systemic embolism occurring and 
the cost of the thrombolytic agent is relatively low. (2). 
Due to the relatively short time the catheter remains in 
the artery the risk of percatheter thrombosis develop- 
ing is low. (3) There is a comparable rapid restoration 
of flow and therefore it is also suitable for treating 
acute critical ischaemia. (4) Avoidance of repeated 
transporting and transferring patients with an 
indwelling intra-arterial catheter. 
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